Betz G, Miller H H, Hales D B
Am J Obstet Gynecol. 1981 Dec 15;141(8):962-72. doi: 10.1016/s0002-9378(16)32688-6.
The mechanism of action of danazol has not been established and the drug may act at multiple loci. Effects suggesting inhibition of pituitary gonadotropin release have been described while some in vitro studies have demonstrated competitive inhibition of steroidogenic enzymes. In addition, destruction of cytochrome P-450 by the acetylenic moiety of danazol is a possible mechanism. Following 14 days of danazol treatment (10 mg/kg/day), the specific content of rat testis microsomal cytochrome P-450 and the serum testosterone were decreased, in spite of no significant change in serum luteinizing hormone. Furthermore, simultaneous administration of human chorionic gonadotropin with danazol still resulted in a decrease in cytochrome. The activities of two testicular microsomal steroid-converting enzymes (17 alpha-hydroxylase and 17,20-lyase) were not altered when based on cytochrome P-450 content but were markedly depressed when based on microsomal protein. In liver, danazol showed a similar but less marked dimunition of the cytochrome. Surprisingly, steroid 17 alpha-hydroxylase activity in liver was significantly increased while other cytochrome P-450 dependent enzyme activities were not altered.
达那唑的作用机制尚未明确,该药物可能作用于多个位点。已有报道显示其具有抑制垂体促性腺激素释放的作用,同时一些体外研究表明它对甾体生成酶有竞争性抑制作用。此外,达那唑的乙炔基部分破坏细胞色素P - 450也是一种可能的机制。在给予大鼠达那唑治疗14天(10毫克/千克/天)后,尽管血清黄体生成素无显著变化,但大鼠睾丸微粒体细胞色素P - 450的比含量及血清睾酮水平均下降。此外,同时给予人绒毛膜促性腺激素和达那唑仍会导致细胞色素减少。基于细胞色素P - 450含量时,两种睾丸微粒体甾体转化酶(17α - 羟化酶和17,20 - 裂解酶)的活性未改变,但基于微粒体蛋白时则显著降低。在肝脏中,达那唑使细胞色素出现类似但程度较轻的减少。令人惊讶的是,肝脏中的甾体17α - 羟化酶活性显著增加,而其他细胞色素P - 450依赖的酶活性未改变。